输血设备的全球市场:规模，占有率，趋势分析(2024年～2030年):MedCore

2023年，全球输液治疗市场规模达117亿美元，较上年112亿美元成长4.5%。据预测，这一数字还将继续上升，复合年增长率 (CAGR) 为 3.7%，最终在预测期内达到 150 亿美元。目前，全球输液治疗市场主要由产业巨头碧迪公司（BD）和贝朗公司推动。

全球输液治疗市场目前正在经历显着成长，这主要是由于新兴市场获得医疗保健服务的机会迅速增加。这些地区的医疗基础设施大大改善，交通便利，这刺激了输液治疗的需求。这些地区的人口增长以及疾病管理和医疗保健服务能力的提高进一步推动了这种不断增长的需求。

加强的医疗保健基础设施正在为更多的人提供输液治疗服务，从而改善患者的治疗效果并扩大治疗选择。新兴市场的这种动态扩张为行业参与者提供了巨大的机会，可以满足对输液治疗解决方案快速增长的需求。

2023年，碧迪公司（BD）巩固了其在全球输液治疗市场的主导地位，在除输液过滤器以外的所有细分市场中均占第一。BD 的非凡成功归功于其强大的全球品牌影响力和广泛的输液治疗产品，这两者都对整体销售成长做出了重大贡献。

贝朗在全球输液治疗市场排名第二。与 BD 一样，贝朗拥有全面的产品组合，涵盖除输液过滤器领域之外的几乎所有细分市场。然而，贝朗值得注意的是，与BD相比，固定设备输液帮浦的选择范围稍窄。

本报告提供全球输血设备市场相关调查，提供市场概要，以及各市场区隔，各地区趋势，竞争情形等资讯。

目录

输血设备市场

• 摘要整理
• 简介
• 市场分析与预测
• 促进因素与阻碍因素
  • 推动市场要素
  • 阻碍市场要素
• 竞争市场占有率分析

In 2023, the global blood transfusion set market reported a total value of $480.1 million, reflecting a 3.5% decline from the $464.1 million recorded in 2022. However, projections for the upcoming period indicate a positive growth trajectory, with a compound annual growth rate (CAGR) of 3.0%, ultimately reaching $591 million. Currently, the global blood transfusion set market is under the dominion of Becton Dickinson (BD), Baxter, and ICU Medical.

Our comprehensive medical market research encompassed a thorough analysis of more than 15 blood transfusion companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.

DATA TYPES INCLUDED:

• Unit Sales, Average Selling Prices, Market Value & Growth Trends

• Forecasts Until 2030, and Historical Data to 2020

• Market Drivers & Limiters for Each Segment

• Competitive Analysis with Market Shares for Each Segment

• Recent Mergers & Acquisitions

• COVID19 Impact

• Disease Overviews and Demographic Information

• Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL BLOOD TRANSFUSION MARKET INSIGHTS

The prevalence of chronic illnesses like cancer, cardiovascular diseases, and blood disorders is on the rise, leading to an increased need for regular blood transfusions as a crucial aspect of treatment. With the growing incidence of these conditions, the demand for blood transfusion kits becomes even more pronounced, serving as a lifeline for individuals grappling with these significant health challenges. The increasing prevalence of chronic diseases underscores the essential role played by blood transfusion kits in providing essential care and support to those in need, ultimately contributing to improved healthcare outcomes.

GLOBAL BLOOD TRANSFUSION MARKET SHARE INSIGHTS

Becton Dickinson (BD) secured its top position among competitors in the blood transfusion device market. BD offered a comprehensive range of blood IV sets, available in both pump-based and gravity-based configurations. These sets featured essential components such as a 180-µm filter, a pressure pump, a needleless connector, and male Luer lock adapters. They were specifically designed for use with BD's Alaris brand of infusion pumps. BD's presence in the IV set market was substantial, and in 2015, the company bolstered its industry standing by acquiring infusion therapy products from CareFusion.

Baxter held the second spot in the blood transfusion device market. The company provided a diverse array of blood collection and administration sets, including standard blood in-line filters, Y-sites, male Luer lock injection adapters, and a pressure pump. Baxter's robust position in both the IV set and infusion pump markets allowed them to drive sales of blood sets effectively. Their product lineup encompassed dual-chamber and single-chamber devices.

ICU Medical, ranking third among competitors in the blood transfusion device market, demonstrated particular strength in North America. The company boasted an extensive range of products and disposables within its infusion therapy portfolio, which was further expanded through the acquisition of Smiths Medical. ICU Medical offered transfusion sets compatible with both gravity and infusion pumps. Additionally, they provided three distinct blood collection and administration tubing options, along with associated accessories, as part of their Saf-T Wing™ product line.

MARKET SEGMENTATION SUMMARY

Blood Transfusion Market

Table of Contents

Blood Transfusion Device Market

• Executive Summary
  • Global Blood Transfusion Device Market Overview
  • Competitive Analysis
  • Regions Included
• Introduction
• Market Analysis and Forecast
• Drivers and Limiters
  • Market Drivers
  • Market Limiters
• Competitive Market Share Analysis

LIST OF CHARTS

• Chart 11-1: Blood Transfusion Device Market, Global, 2023 & 2030
• Chart 11-2: Blood Transfusion Device Units Sold, Global, 2023
• Chart 11-3: Blood Transfusion Device Market, Global, 2020 - 2030
• Chart 11-4: Leading Competitors, Blood Transfusion Device Market, Global, 2023

LIST OF FIGURES

• Figure 11-1: Blood Transfusion Device Regions Covered, Global (1 of 2)
• Figure 11-2: Blood Transfusion Device Regions Covered, Global (2 of 2)
• Figure 11-3: Blood Transfusion Device Market, Global, 2020 - 2030
• Figure 11-4: Units Sold by Region, Blood Transfusion Device Market, Global, 2020 - 2030
• Figure 11-5: Average Selling Price by Region, Blood Transfusion Device Market, Global, 2020 - 2030 (US$)
• Figure 11-6: Market Value by Region, Blood Transfusion Device Market, Global, 2020 - 2030 (US$M)
• Figure 11-7: Leading Competitors, Blood Transfusion Device Market, Global, 2023